Pfizer Inc said on Thursday it plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dublin, which would double the capacity to produce key substances used in biological drugs.
The company last year began producing an ingredient for its COVID-19 vaccine at the facility in Grange Castle, Dublin. $Pfizer(PFE)$ bullish
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments